Scilex Holding Co

Scilex Holding Company, trading under the ticker SCLX, is a special purpose acquisition company that conducted its initial public offering in 2021 with a stated focus on the healthcare and life sciences sector. The company filed an amended quarterly report on Form 10-Q/A with the Securities and Exchange Commission on August 24, 2021, joining a broad group of blank-check issuers that revised their financial disclosures during that period following SEC guidance on the accounting classification of warrant instruments. As of that filing date, Scilex Holding remained in its business combination search phase, evaluating potential merger targets in the pharmaceutical and medical space. For the full filing history, sponsor details, and real-time deal status on SCLX, sign up for complete data access at SpacDesk.